Verona PharmaVRNA
13F holders, Q4 2025 (December 31)1holders −242
0new positions
238sold out
$17.95avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Verona Pharma Ltd. (VRNA) in their 13F filings, down 242 from Q3 2025. 0 opened new positions and 238 sold out. The largest holder was DekaBank Deutsche Girozentrale ($359K).
- Company
- Verona Pharma Ltd.
- CUSIP
- 925050106
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 238 | $8.5B |
All 13F filers, Q3 2025 → Q4 2025: 80,144,629 shares sold, net −80,144,629 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| DekaBank Deutsche Girozentrale | 0.00% | No change | 20,000 | $359K |
"% of holder's portfolio" is VRNA's weight in each manager's 13F, not the share of Verona Pharma Ltd. the manager owns.